Excess Iodine Exposure Acutely Increases Salivary Iodide And Antimicrobial Hypoiodous Acid Concentrations In Humans

Yasutada Akiba, Angela M. Leung, Muhammad-Tariq Bashir, Ramin Ebrahimi, Jesse W. Currier, Natalia Neverova, Jonathan D. Kaunitz

TL;DR

This study demonstrates that an acute "load" of iodine significantly increases the concentration of hypoiodous acid (HOI)—a potent natural disinfectant—in human saliva. The findings suggest that safe iodide supplementation could potentially "supercharge" our innate oral and respiratory defenses against airborne viruses like SARS-CoV-2 and influenza.

What Problem Does This Paper Address?

Our bodies possess an endogenous "disinfectant factory" known as the lactoperoxidase (LPO) system. Located in our saliva and airway linings, this system uses hydrogen peroxide to convert iodide ($I^-$) and thiocyanate ($SCN^-$) into antimicrobial hypohalites: hypoiodous acid (HOI) and hypothiocyanite ($OSCN^-$).

While we know these compounds can kill viruses in a lab setting, we haven't known if we can actually increase their production in living humans. The authors hypothesized that the LPO system is substrate-limited—meaning it has the machinery to make more disinfectant, but it lacks the "raw materials" (iodide). This paper investigates whether increasing systemic iodine levels can safely boost the concentration of these antiviral agents in the mouth.

Methods

The researchers conducted a prospective study on patients undergoing routine coronary angiography at the West Los Angeles VA Medical Center. This clinical setting provided a unique opportunity: angiography requires the injection of iodinated contrast dye, which delivers a massive (but clinically standard) dose of iodine.

  • Subjects: 40 patients were analyzed across two sub-studies.
  • Intervention: Intra-arterial injection of 25–230 ml of iodinated contrast medium (Visipaque®-320).
  • Sampling: Saliva was collected at baseline and at multiple intervals (3–6 hours, 24 hours, and up to 48 hours post-injection).
  • Analytical Techniques:
    • Iodide: Measured via an ion-selective electrode.
  • HOI: Measured using a novel assay based on the conversion of NADPH to iodinated NADPH (NADPI).
  • $SCN^-$ and $OSCN^-$: Measured via ferric colorization and Ellman’s reagent, respectively.

Datasets

This was a primary clinical study; no external datasets were used. The data consists of original biochemical measurements from the 40 enrolled human subjects.

Key Insights and Ideas

  • The Substrate Bottleneck: The most significant "aha" moment is that the LPO system is indeed limited by iodide availability. While thiocyanate ($SCN^-$) levels in saliva remained unchanged, iodide and its byproduct (HOI) spiked dramatically.
  • Direct Correlation: There is a linear relationship between the iodine load in the blood and the iodide output in saliva. This confirms that the salivary glands actively "trap" and concentrate iodide from the circulation.
  • Sustained Defense: The increase in salivary HOI wasn't just a brief spike; levels remained elevated for at least 24 hours, and in some cases up to 48 hours, suggesting that a single dose of iodine provides a window of enhanced protection.
  • The "Asian Anomaly" Connection: The authors suggest this biochemical mechanism might explain why countries like Japan and South Korea—where diets are naturally rich in iodine-heavy seaweed—saw lower COVID-19 mortality rates early in the pandemic despite high population densities.

Key Results

  • Iodide Surge: In Study 1, median salivary iodide jumped from 16.7 $\mu M$ at baseline to 331.9 $\mu M$ post-exposure ($p < 0.0001$).
  • HOI Boost: Salivary HOI concentrations increased from a median of 1.6 $\mu M$ to 5.1 $\mu M$ ($p < 0.0001$).
  • Viricidal Threshold: Previous research suggests that $\sim10 \mu M$ of HOI is required to kill influenza and coronaviruses. While the median post-exposure level was $5.8 \mu M$, many individual subjects reached or exceeded the $10 \mu M$ threshold.
  • Specificity: There was no significant change in the thiocyanate ($SCN^-$) or hypothiocyanite ($OSCN^-$) levels, proving that the iodine load specifically targets the HOI pathway of the LPO system.

Limitations and Future Work

  • Observational Nature: The study used IV contrast dye, which is a very different delivery method than oral supplements (like potassium iodide tablets).
  • Sample Size: With only 40 patients, the study is relatively small and focused on a specific demographic (mostly veterans undergoing heart procedures).
  • No Direct Viral Testing: While the paper measures the concentration of HOI, it does not directly test if the "boosted" saliva from these patients actually kills SARS-CoV-2 in a petri dish.
  • Future Directions: The authors call for clinical trials to determine if oral iodide supplementation (at doses within the "Tolerable Upper Limit" of 1,100 $\mu g/day$) can achieve similar results and effectively reduce viral transmission in the real world.

Summary updated

Abstract

Abstract The lactoperoxidase (LPO)-hydrogen peroxide-halides reaction (LPO system) converts iodide and thiocyanate (SCN - ) into hypoiodous acid (HOI) and hypothiocyanite (OSCN - ), respectively. Since this system has been implicated in defense of the airways and oropharynx from microbial invasion, we measured the concentrations of these analytes in human saliva before and after iodine administration to test the hypothesis that an iodide load increases salivary iodide and HOI concentrations. Salivary iodide, SCN - , HOI and OSCN - were measured using standard methodology. Salivary iodide and HOI levels significantly increased after iodinated contrast injection compared with baseline levels, whereas there was no significant change in salivary SCN - and OSCN - levels. The contrast dye iodine load and changes of salivary iodide and HOI levels were positively correlated, suggesting that higher iodide in the circulation increases iodide output and salivary HOI production. Excess iodine exposure in humans increases the salivary output of iodide, increasing salivary HOI concentrations with no effect on SCN - /OSCN - levels. This first of its kind study suggests that a sufficient but safe iodide supplementation may augment the generation of antimicrobial HOI by the salivary LPO system against airborne viral pathogens, including coronaviruses and influenza viruses, a possible inexpensive means of effectively curbing viral pandemics.
BibTeX
@inproceedings{akiba2022excess,
  author = {Yasutada Akiba and Angela M. Leung and Muhammad-Tariq Bashir and Ramin Ebrahimi and Jesse W. Currier and Natalia Neverova and Jonathan D. Kaunitz},
  title = {{Excess Iodine Exposure Acutely Increases Salivary Iodide And Antimicrobial Hypoiodous Acid Concentrations In Humans}},
  booktitle = {Scientific},
  year = {2022},
  doi = {10.1038/s41598-022-23803-8},
}
Figure